K-pop

Duo Hanmaum, known for "Gatbawi," to Hold Free Concert on the 30th

At the outdoor stage of Sorisovillage Theme Park in Namyangju "Delivering a Moving Performance That Blends Folk and Rock"

KIM HYUNSIK
2026-08-13 17:47:39
[Edaily Starin KIM HYUNSIK Reporter] The duo Hanmaum announced on the 13th that they will hold a free concert at 4:00 p.m. on the 30th on the outdoor stage at Sorisobillage Theme Park in Namyangju.
Kang Young-chul (left), Yoo Young-min (Photo courtesy of Hanmaum)
Hanmaum began in 1981 as a mixed-gender duo consisting of Kang Young-chul and Yang Ha-young. After gaining popularity with songs such as “Heartache” and “Seaside Rock,” they disbanded in 1987.
Later, Kang Young-chul reformed Hanmaum as a male duo with Yoo Young-min, a former member of the group Beodeulpiri who had gained recognition for songs like “The Girl with Big Eyes” and “Rose.” Hanmaum announced a fresh start in 2023 with the release of their first full-length album, “GREATEST HITS.”
They will share the stage for this concert with bassist Ko Hyo-min. Hanmaum stated, “Through a performance that blends folk and rock, we will deliver a sense of connection and emotion that transcends generations,” adding, “We hope you’ll enjoy the music comfortably outdoors with your family, friends, and loved ones while savoring the coming fall.”

Economy

Corporation

IT·Science

Economy

SMEC CO.,LTD’s Appeal Dismissed… Preliminary Injunction Allowing SNT Holdings to Inspect Accounting Records Upheld

A court ruling allowing SNT Holdings—which is embroiled in a management control dispute with SMEC CO.,LTD—to inspect and copy SMEC CO.,LTD’s accounting records and other documents has been upheld even…
2026-08-14 23:08:42

Corporation

Lotte’s Shin Dong-bin Tops the List of Retail Industry Leaders in Compensation for the First Half of This Year

Shin Dong-bin, Chairman of Lotte Group, received the highest compensation among the heads of major retail companies in the first half of this year. Shin Dong-bin, Chairman of Lotte Group. (Photo co…
2026-08-14 20:18:41

IT·Science

JWPHARMACEUTICAL Files IND Application for Phase 3 Domestic Clinical Trials of 'Once-Every-Two-Weeks' Weight-Loss Drug

JWPHARMACEUTICAL CI (Photo courtesy of JWPHARMACEUTICAL) JWPHARMACEUTICAL(001060)announced on the 14th that it has submitted an Investigational New Drug (IND) application to the Ministry of Food a…
2026-08-14 22:35:03